BPC 157 Oral Supplements vs Injection: Which is Better? – Paradigm Peptides

Peptide therapy is a popular option for those looking to heal their body in a natural, holistic way. Supplements like BPC 157 have been proven in study after study to expedite healing and recovery, and to offer relief from common diseases. This particular supplement is derived from human gastric juice, meaning it is widely tolerated and has virtually no risk of rejection or serious side effects.

As you buy BPC 157, however, there are a few key decisions you’ll need to make. One of the more fundamental decisions is over your peptide delivery system. BPC 157 can be administered in a couple of forms, orally or via subcutaneous injection. The question is, which of these delivery systems is best-suited to promote your health and to restore blood flow to injured parts of your body?

BPC 157: Choosing the Best Route of Administration

First and foremost, understand that both oral capsules and subcutaneous injection have been shown to benefit the human body. Each delivery system has been linked with the healing process, including healing in tendons, ligaments, the digestive tract, and other regenerative effects. Both capsules and injections can help to restore collagen production and improve access to blood vessels, all of which helps with bone healing and soft tissue healing.

With that said, BPC 157 benefits may be more pronounced with the subcutaneous injection route. The reason for this is simple: bio-absorption. That is, with injections, more of the peptide is absorbed into the body, and at a faster rate. This enhances the systemic effects that you experience.

BPC 157 Delivery Systems: A Closer Look at the Evidence

In considering the two methods for using BPC 157, it may also be helpful to survey human studies and other forms of research. Consider just a few representative data points.

What Studies Say About Oral Administration

There is plenty of research to show that oral administration has a positive effect on the body, including evidence showing that oral administration can improve the connection between the brain and the gastrointestinal tract. Moreover, getting the right BPC 157 dosage can lead to long-lasting relief from ulcers and related conditions.

What Studies Say About BPC 157 Injections

With that said, there is also a growing body of evidence to show that BPC 157 capsules are less effective than injections, making injections the preferred method of administration for those seeking a faster recovery. Clinical studies, including animal studies, have shown that injections are simply more effective at healing stomach ulcers and similar concerns.

Choosing  BPC 157 Peptide Therapy from Paradigm Peptides

In short, BPC 157 can offer many potential healing benefits, but the most effective way to harness those benefits is through injections. That’s the delivery method we offer at Paradigm Peptides. Buy BPC 157 from Paradigm Peptides for a high quality, pharmaceutical grade product you trust.

Frequently Asked Questions About BPC 157 Administration

What is the injection of BPC-157?

Simply put, this is the subcutaneous injectable form of a stable gastric peptide that has been clinically proven to provide a number of wound healing effects, and to promote recovery from conditions such as inflammatory bowel disease.

Can BPC-157 be taken orally?

Oral BPC 157 is generally considered to be safe and effective, though injections are the preferred route of administration, as they offer a higher absorption rate than oral forms.

Does oral BPC 157 work?

Oral administration can be effective at repairing tissue damage, though it is generally considered to be less beneficial than injections.

References

Chang, C., Tsai, W., Hsu, Y., & Pang, J. (2014). Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecules, 19, 19066 – 19077. https://doi.org/10.3390/molecules191119066.

Duzel A, Vlainic J, Antunovic M, Malekinusic D, Vrdoljak B, Samara M, Gojkovic S, Krezic I, Vidovic T, Bilic Z, Knezevic M, Sever M, Lojo N, Kokot A, Kolovrat M, Drmic D, Vukojevic J, Kralj T, Kasnik K, Siroglavic M, Seiwerth S, Sikiric P. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J Gastroenterol. 2017 Dec 28;23(48):8465-8488. doi: 10.3748/wjg.v23.i48.8465. PMID: 29358856; PMCID: PMC5752708.

Xue, X., Wu, Y., Gao, M., Li, W., Zhao, N., Wang, Z., Bao, C., Yan, Z., & Zhang, Y. (2004). Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats.. World journal of gastroenterology, 10 7, 1032-6. https://doi.org/10.3748/WJG.V10.I7.1032.

Chang, C., Tsai, W., Lin, M., Hsu, Y., & Pang, J. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.. Journal of applied physiology, 110 3, 774-80. https://doi.org/10.1152/japplphysiol.00945.2010.